Skip to content

GENEWIZ WEEK 2025 WORKSHOP

The Clone-Files:

Data-Driven Antibody Engineering with the PROPHET-Ab Platform

Premieres Wednesday, September 10, 2025 | 11:00 AM EDT | 5:00 PM CET
 
 
GWeek25_Icons_Color_Workshops

About the workshop

Explore how the PROPHET-Ab platform leverages AI/ML-based modeling to generate predictive insights into antibody developability. This session will show how design and evaluation workflows can get jiggy with predictive modeling to streamline therapeutic antibody development by identifying key properties early in the pipeline.

The discussion will highlight real-world applications of PROPHET-Ab and showcase how advanced modeling is transforming candidate selection and optimization, like taking dial-up to DSL!

What you'll learn about

  • Discover how AI/ML tools are used to predict developability properties for antibody candidates.

  • Understand how data-driven strategies can accelerate therapeutic antibody development.

  • Learn how to integrate predictive modeling into your discovery workflow to reduce risk and improve efficiency.

About the presenter

Untitled design - 2025-07-25T163424.046

Ammar Arsiwala, Ph.D. 

Director, Antibody Development Gingko Bioworks, Inc

Dr. Ammar Arsiwala currently leads the Antibody Developability team at Gingko Bioworks, overseeing the development of methods and workflows for high-throughput (HT) antibody production and biophysical assay characterization to support antibody AI/ML modeling and drug discovery. Dr. Arsiwala earned his PhD from Georgia Institute of Technology, with a focus on the design of broadly protective vaccines for infectious diseases and previously worked at Amgen Inc. in late-stage antibody process development.

Register Now